{"resourceType":"ValueSet","meta":{"lastUpdated":"2015-08-25T06:59:17.671+10:00","profile":["http://hl7.org/fhir/StructureDefinition/valueset-shareable-definition"]},"url":"http://hl7.org/fhir/ValueSet/v3-ActSubstanceAdminSubstitutionCode","version":"2014-03-26","name":"ActSubstanceAdminSubstitutionCode","status":"active","experimental":false,"expansion":{"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-expansionSource","valueReference":{"reference":"ValueSet/v3-ActSubstanceAdminSubstitutionCode"}}],"identifier":"urn:uuid:fa9ba24d-d771-4b37-8f99-9bc66c78aa75","timestamp":"2015-08-24T21:04:55Z","contains":[{"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-definition","valueString":"Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product."}],"system":"http://hl7.org/fhir/v3/substanceAdminSubstitution","code":"E","display":"equivalent"},{"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-definition","valueString":"Description:                                                    Substitution occurred or is permitted with another product that is a:                                                      pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester                            pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration                                                                              Examples:                                                                                                               Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate                                                           Pharmaceutical equivalent: Lisonpril for Zestril"}],"system":"http://hl7.org/fhir/v3/substanceAdminSubstitution","code":"EC","display":"equivalent composition"},{"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-definition","valueString":"Description:                                                    Substitution occurred or is permitted between equivalent Brands but not Generics                                                      Examples:                                                                                Zestril  for Prinivil                            Coumadin for Jantoven"}],"system":"http://hl7.org/fhir/v3/substanceAdminSubstitution","code":"BC","display":"brand composition"},{"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-definition","valueString":"Description: Substitution occurred or is permitted between equivalent Generics but not Brands                                                      Examples:                                                                                Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)"}],"system":"http://hl7.org/fhir/v3/substanceAdminSubstitution","code":"G","display":"generic composition"},{"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-definition","valueString":"Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.                                                      Examples:                                                                                ranitidine for Tagamet"}],"system":"http://hl7.org/fhir/v3/substanceAdminSubstitution","code":"TE","display":"therapeutic alternative"},{"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-definition","valueString":"Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics >                            Examples:                                                                                Zantac for Tagamet"}],"system":"http://hl7.org/fhir/v3/substanceAdminSubstitution","code":"TB","display":"therapeutic brand"},{"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-definition","valueString":"Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands >                            Examples:                                                                                Ranitidine  for cimetidine"}],"system":"http://hl7.org/fhir/v3/substanceAdminSubstitution","code":"TG","display":"therapeutic generic"},{"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-definition","valueString":"Description: This substitution was performed or is permitted based on formulary guidelines."}],"system":"http://hl7.org/fhir/v3/substanceAdminSubstitution","code":"F","display":"formulary"},{"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-definition","valueString":"No substitution occurred or is permitted."}],"system":"http://hl7.org/fhir/v3/substanceAdminSubstitution","code":"N","display":"none"}]}}